Entheon Biomedical Corp
OTC:ENTBF
Balance Sheet
Balance Sheet Decomposition
Entheon Biomedical Corp
Entheon Biomedical Corp
Balance Sheet
Entheon Biomedical Corp
| Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
3
|
2
|
1
|
0
|
|
| Cash |
3
|
2
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
0
|
0
|
|
| Total Current Assets |
4
|
3
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
6
|
0
|
0
|
|
| Long-Term Investments |
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
10
+123%
|
1
-92%
|
0
-48%
|
|
| Liabilities | |||||
| Accounts Payable |
1
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+27%
|
0
-83%
|
0
-45%
|
|
| Equity | |||||
| Common Stock |
7
|
19
|
19
|
20
|
|
| Retained Earnings |
3
|
10
|
19
|
20
|
|
| Total Equity |
4
N/A
|
9
+142%
|
1
-93%
|
0
-49%
|
|
| Total Liabilities & Equity |
4
N/A
|
10
+123%
|
1
-92%
|
0
-48%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
1
|
6
|
6
|
6
|
|